moxisylyte has been researched along with Bladder Disorder, Neurogenic in 2 studies
Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
Excerpt | Relevance | Reference |
---|---|---|
"The effect on the spastic striated pelvic sphincters may be central, whereas the effect on the smooth muscle may be peripheral." | 1.26 | Effect of the alpha-adrenergic blocking agent thymoxamine on the neurogenic bladder and urethra. ( Klemar, B; Pedersen, E; Tørring, J, 1980) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pedersen, E | 1 |
Tørring, J | 1 |
Klemar, B | 1 |
Perrigot, M | 1 |
Vannier, A | 1 |
Bor, Y | 1 |
2 other studies available for moxisylyte and Bladder Disorder, Neurogenic
Article | Year |
---|---|
Effect of the alpha-adrenergic blocking agent thymoxamine on the neurogenic bladder and urethra.
Topics: Adolescent; Adult; Electromyography; Female; Humans; Male; Middle Aged; Moxisylyte; Muscle Spasticit | 1980 |
[Alpha adrenergic blocking agents in disorders of the bladder sphincter].
Topics: Adrenergic alpha-Antagonists; Adult; Female; Humans; Male; Moxisylyte; Nicergoline; Phenoxybenzamine | 1986 |